CSI Market
Sign In | Register

Bausch Health Companies Inc (BHC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BHC Annual Cash Flow →
Reviewing cash flow figures over time highlights how Bausch Health Companies Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-1,423.00
Depreciation & amortization295.00
Amortization of Other Assets14.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges12.00
Provision For Loan Losses Expensed2.00
Increase (Decrease) in Inventories14.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total3.00
Share-based Compensation52.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-11.00
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset-
Allowances For Losses On Accounts Receivable And Inventories26.00
Deferred Income Tax Noncash Expense Benefit30.00
Non Cash Cost Alliance Revenue-
Gain Loss Related To Litigation Settlement-
Payment Of Accreted Interest On Repurchase Of Convertible Debt-
Employee Service Share Based Compensation Tax Benefit From Compensation Expense-
Acquisition Accounting Adjustment On Inventory Sold-
Derivative Gain Excluded Component-3.00
Payment For Debt Extinguishment Or Debt Prepayment Cost Operating Activities-
Payment For Contingent Consideration Liability Including Accretion Operating Activities-3.00
Gain Loss Related To Litigation Settlement Gross10.00
Foreign Currency Transaction And Other Gain Loss Before Tax5.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-148.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-150.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets27.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net-8.00
Payments for (Proceeds from) Other Operating Activities1,280.00
Discontinued operations0.00
Net Cash flow from Operating Activities230.00
Investing Activities
Capital Expenditures38.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities1.00
Payments to Acquire Marketable Securities1.00
Payments for (Proceeds from) Hedge, Investing Activities-5.00
Interest Settlement On Cross Currency Swaps-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested3.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-139.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions1.00
Long-term debt - borrowings2,802.00
Long-term debt - repayments2,857.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net34.00
Other net-1,382.00
Payments Of Contingent Consideration-
Settlement Of Convertible Debt-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1,325.00
Payment Of Deferred Consideration-
Restricted Cash Current13.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits-
Restricted Cash And Other Settlement Deposits Current-
Proceeds From Issuance Initial Public Offering Net Of Costs Related Party-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-100.00
Effect of exchange rate on cash flow-4.00
Discontinued operations0.00
Free Cash Flow268.00
Total Cash Flow-13.00
4 historic quarters locked

Sign in to unlock the full Bausch Health Companies Inc cash flow history.

Sign In Create Free Account

About Bausch Health Companies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 30, 2026
  • Source: bhc-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000885590-26-000107

Figures are derived from filed reports and may be restated. Historical data is subject to revision.